TheraNova and UCSF Surgical Innovations Announce Partnership to Accelerate MedTech Innovation

TheraNova, LLC, and UCSF Surgical Innovations today announced a partnership that aims to co-develop device technologies for unmet patient needs.

Online PR News � 04-June-2018 – TheraNova and UCSF Surgical Innovations Announce Partnership to Accelerate MedTech Innovation

San Francisco medtech innovation company TheraNova, LLC, and UCSF Surgical Innovations, an incubator-accelerator for University of California, San Francisco (UCSF) medtech innovators, today announced a partnership that aims to co-develop device technologies for unmet patient needs.

The partnership agreement establishes mechanisms for collaboration and access to expertise at both sites, enabling supported technologies to benefit from UCSFs intellectual and clinical environment and TheraNovas comprehensive product development capabilities.

Surgical Innovations is a five-year-old initiative of UCSFs Departments of Surgery and Bioengineering & Therapeutic Sciences designed to nurture and drive early-stage device technologies toward clinical use. The program has advanced eight novel devices to first-in-human trials and attracted over $30 million in grants and seed-stage investments.

As a major source of medtech innovation in San Francisco, UCSF has an unparalleled environment for device invention at the doorstep of Silicon Valley. We have world-class clinical key opinion leaders, state-of-the-art research facilities, leading translational bioengineers and passionate trainees working at the frontier of patient care, says Hanmin Lee, MD, surgeon-in-chief of UCSF Benioff Childrens Hospital and Surgical Innovations clinical lead.

Located blocks from UCSFs Mission Bay campus, medtech and digital health innovator TheraNova has been committed to developing innovative solutions addressing large unmet needs and bringing them to market with in-house capabilities including R&D, clinical, regulatory, quality, intellectual property and business development. Since 2006, TheraNova has created 14 spin-off companies that have raised over $280 million in venture funding.

TheraNova CEO Dan Burnett, MD, has long advised projects and collaborated with different programs at UCSF. As the Industry Director of the UC Berkeley-UCSF Master of Translational Medicine program I have been impressed with the caliber of both the students and the faculty. With this official partnership with Surgical Innovations, we are hoping to work more closely with UCSF innovators to bring more impactful products to market, says Burnett.

The partnership will enable TheraNova projects and spinouts to access UCSF expertise and collaborators for clinical trials and academic grants. UCSF technologies in turn will benefit from access to TheraNovas certified manufacturing facilities; engineering, market analysis, and business development expertise; and fundraising experience. The collaboration agreement also outlines provisions for the development of joint inventions.

UCSF has a long history of collaborating with external partners to translate our research into actual products, says UCSF professor of bioengineering Shuvo Roy, PhD. TheraNova has resources in every step of the device development process, and we look forward to utilizing their expertise and working together to accelerate groundbreaking innovation to patients.

About TheraNova
TheraNova is a San Francisco-based medical device developer with a track record of creating innovative and practical solutions to large markets with unmet needs. Theranovas triple aim is to create technologies with the potential to improve outcomes for patients, expand access to healthcare and reduce cost for patients or payers.

About UCSF Surgical Innovations
Surgical Innovations is an initiative of the UCSF Department of Surgery in partnership with the UCSF Department of Bioengineering & Therapeutic Sciences to identify, mentor, and facilitate the translation of novel medical technologies into transformative new devices and treatments to improve patient care.

About UCSF
UC San Francisco (UCSF) is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It includes top-ranked graduate schools of dentistry, medicine, nursing and pharmacy; a graduate division with nationally renowned programs in basic, biomedical, translational and population sciences; and a preeminent biomedical research enterprise. It also includes UCSF Health, which comprises three top-ranked hospitals, UCSF Medical Center and UCSF Benioff Childrens Hospitals in San Francisco and Oakland, and other partner and affiliated hospitals and healthcare providers throughout the Bay Area.